U-PVCT

Q:PVCT - PROVECTUS BIOPHARMACEUTICALS INC - https://www.pvct.com

00:00:55 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
PVCT - Q	not subscribed					0.0875	+0.006	7.4	39.2	3	10	0.0816 0.0877 0.0816	0.199 0.0445	13:29:12	Jan 14	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market: OTC Markets -- Tier: OTCQB -- Status: Active

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - All 10 today

More trades...

Time ET	Ex	Price	Change	Volume
13:29:12	Q	0.0875	0.006	12,000
11:23:14	Q	0.0875	0.006	3,000
11:23:14	Q	0.08682	0.00532	3,000
10:32:40	Q	0.08753	0.00603	10
10:32:40	Q	0.0877	0.0062	4,990
10:26:38	Q	0.0841	0.0026	14,000
09:54:16	Q	0.08685	0.00535	1,100
09:33:39	Q	0.08205	0.00055	620
09:30:00	Q	0.08205	0.00055	263
09:30:00	Q	0.0816	0.0001	264

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-01-14 08:00	U:PVCT	News Release200	Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus's Spinoff Company for Rose Bengal-Based Eye Drugs
2024-12-11 09:00	U:PVCT	News Release200	Provectus Biopharmaceuticals Launches VisiRose, Provectus's Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
2024-10-24 08:00	U:PVCT	News Release200	Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
2024-10-10 08:00	U:PVCT	News Release200	Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
2024-06-13 08:00	U:PVCT	News Release200	Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders
2024-05-21 08:00	U:PVCT	News Release200	Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting
2024-05-14 08:00	U:PVCT	News Release200	Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2024 Annual Meeting
2024-05-02 08:00	U:PVCT	News Release200	Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of Rose Bengal Sodium in Hematology (Leukemia)

Date ET

Symbol

Type

Headline

2025-01-14 08:00

U:PVCT

News Release

Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus's Spinoff Company for Rose Bengal-Based Eye Drugs

2024-12-11 09:00

U:PVCT

News Release

Provectus Biopharmaceuticals Launches VisiRose, Provectus's Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology